Orforglipron
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 974
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Orforglipron (GZL1) | Hypertension | n/r | n/r | n/r | n/r |
| Orforglipron (GZL2) | Hypertension | n/r | n/r | n/r | n/r |